By Jamie Lennox ( October 26, 2026, 8:13 PM GMT) -- The Unified Patent Court has said it could stop Novo Nordisk from playing what Sandoz calls the "divisional game" during the pair's ongoing Ozempic dispute, signaling an intention to keep patent holders from using divisional applications to repeatedly sidestep validity rulings in Europe....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.